Last update 21 Nov 2024
Navivumab
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Monoclonal antibody |
Synonyms + [1] |
Target |
Mechanism hemagglutinin modulators(Influenza virus hemagglutinin glycoproteins modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Gene Sequence
Sequence Code 9053374L
Source: *****
Sequence Code 316784540H
Source: *****
Related
5
Clinical Trials associated with NavivumabA Phase IIb, Randomized, Double-blind, Multicenter, Placebo-controlled Study Evaluating the Efficacy and Safety of CT-P27 in Subjects with Acute Uncomplicated Influenza A Infection
A Phase IIb, Randomized, Double-blind, Multicenter, Placebo-controlled Study Evaluating the Efficacy and Safety of CT-P27 in Subjects With Acute Uncomplicated Influenza A Infection
A Randomised, Double-Blind, Placebo-Controlled, Single-Centre, Phase IIa Study in Healthy Volunteers to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model
100 Clinical Results associated with Navivumab
Login to view more data
100 Translational Medicine associated with Navivumab
Login to view more data
100 Patents (Medical) associated with Navivumab
Login to view more data
1
Literatures (Medical) associated with NavivumabPLOS ONEQ3 · CROSS-FIELD
Broader neutralization of CT-P27 against influenza A subtypes by combining two human monoclonal antibodies
Q3 · CROSS-FIELD
ArticleOA
Author: Ryu, Dong-Kyun ; Shin, JiYoung ; Lee, Soo-Young ; Choi, Jung-Ah ; Yi, Kye Sook ; Lee, Sena ; Lee, Eun Beom ; Son, Dain ; Chae, Ji-Sang ; Song, Manki ; Yang, Eunji ; Kim, Pankyeom ; Im, Bok-Hyeon ; Park, Hayan ; Lee, HyunJoo
100 Deals associated with Navivumab
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Influenza A virus infection | Phase 2 | - | - | |
| Influenza A virus infection | Phase 2 | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 2 | 228 | (CT-P27 90 mg/kg) | fucjzwleor(vzqhkfrjcp) = otzxopqpll iduanwpcex (ciowoetazc, pcaeojcefm - hdnmmalqrt) View more | - | 31 Oct 2022 | ||
(CT-P27 45mg/kg) | fucjzwleor(vzqhkfrjcp) = cpwpilpaug iduanwpcex (ciowoetazc, npcvjlppyh - sxtubuftfx) View more | ||||||
Phase 2 | 81 | (CT-P27 10mg/kg) | jvsngmpqhp(sutcyopqkh) = ztaojynqnu cqejxgeeih (dzaphbpyts, hfzdwywmxl - qdiepkfmfx) View more | - | 16 Mar 2020 | ||
(CT-P27 20mg/kg) | jvsngmpqhp(sutcyopqkh) = blegjozapz cqejxgeeih (dzaphbpyts, uutrflbnvk - lalayprlwe) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free